United States · FDA National Drug Code directory
Eltrombopag Olamine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60219-1414_992e50d5-b6c2-4213-9c7c-ef25c84d0708
- Product NDC
- 60219-1414
- Form
- TABLET, FILM COATED
- Composition / generic term
- Eltrombopag
- Labeler
- Amneal Pharmaceuticals NY LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260115
- Source listing expiry
- 20271231
Source-listed ingredients
- ELTROMBOPAG OLAMINE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (60219-1414-3) · 60219-1414-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →